Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Corcept Therapeutics Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 202
- +6 vs. Q2 2021
- Shares held
- 80.9M
- +390.4K (+0.5%) vs. Q2 2021
- Total value
- $1.59B
- −$177.3M (−10.0%) vs. Q2 2021
- New holders
- 27
- 62 more added
- Sold out
- 21
- 76 more reduced
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CORT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 424 | $7.15B |
| Q1 2026 | 352 | $3.20B |
| Q4 2025 | 390 | $2.67B |
| Q3 2025 | 429 | $6.41B |
| Q2 2025 | 422 | $5.79B |
| Q1 2025 | 422 | $9.24B |
| Q4 2024 | 368 | $4.25B |
| Q3 2024 | 321 | $4.09B |
| Q2 2024 | 286 | $2.90B |
| Q1 2024 | 285 | $2.36B |
| Q4 2023 | 274 | $2.75B |
| Q3 2023 | 247 | $2.26B |
| Q2 2023 | 225 | $1.81B |
| Q1 2023 | 233 | $1.89B |
| Q4 2022 | 244 | $1.69B |
| Q3 2022 | 239 | $2.23B |
| Q2 2022 | 226 | $2.02B |
| Q1 2022 | 228 | $1.84B |
| Q4 2021 | 208 | $1.59B |
| Q3 2021 | 202 | $1.59B |
| Q2 2021 | 199 | $1.77B |
| Q1 2021 | 210 | $1.94B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Corcept Therapeutics Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 11,870,518 | $233.6M | 0.01% | −106,866−0.9% | Reduced |
| BlackRock Inc. | 15,593,876 | $306.9M | 0.01% | −26,642−0.2% | Reduced |
| Woodline Partners LP | 0 | $0 | 0.00% | −213,080−100.0% | Sold out |
| BI Asset Management Fondsmaeglerselskab A/S | 0 | $0 | 0.00% | −154,761−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −37,100−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −33,551−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −28,780−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −23,514−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,744−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,918−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,045−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Wealth Architects, LLC | 0 | $0 | 0.00% | −12,390−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −10,064−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −9,941−100.0% | Sold out |
| First Citizens Bank & Trust Co | 0 | $0 | 0.00% | −9,495−100.0% | Sold out |
| Camden Capital, LLC | 0 | $0 | 0.00% | −9,293−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,764−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −2,523−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −1,529−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Bellwether Advisors, LLC | 0 | $0 | 0.00% | −208−100.0% | Sold out |
| Smith Asset Management Group LP | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| First Horizon Corp | – | – | – | – | Not filed |